DataCloudKnowledgetrainingcoordination

Bipolar disorder in remission (Disease Or Phenotype)

Medcin:MEDCIN:357081

Id:ce0c242a-0838-5667-a1de-dfc2ba9a2b9b

Results found

Linked to

	Label	Description
	Phenobarbital indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Li<sup>+</sup> indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Aripiprazole indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone) indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	lamotrigine indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	primidone indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	phenytoin indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Lithium citrate indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-piperazin-1-yl)-ethoxy]-ethanol indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone) indication Bipolar disorder in remission Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Phenobarbital indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Li<sup>+</sup> indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Aripiprazole indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone) indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

lamotrigine indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

primidone indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

phenytoin indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Lithium citrate indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-piperazin-1-yl)-ethoxy]-ethanol indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone) indication Bipolar disorder in remission

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.